NCT03715959 - Nipple Aspirate Fluid in Detecting Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2024

Conditions

Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor NegativeHealthy SubjectHER2 Positive Breast CarcinomaHER2/Neu NegativeLuminal A Breast CarcinomaLuminal B Breast CarcinomaProgesterone Receptor NegativePrognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8Prognostic Stage IIIC Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8Triple-Negative Breast Carcinoma

Interventions

PROCEDURE

Aspiration of Breast

Undergo NAF

PROCEDURE

Biospecimen Collection

Undergo NAF

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors

lead

Ohio State University Comprehensive Cancer Center

OTHER